Navigation Links
Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
Date:8/14/2014

me period in 2013.

Other income was $95,000 and $96,000 for the three and six months ended June 30, 2014, respectively, compared to other expense of $36,000 and $24,000 for the same periods in 2013.

Conference CallSynthetic Biologics will hold a conference call today, Thursday, August 14, 2014, at 8:30 am EDT, during which Mr. Riley will provide an operational update and C. Evan Ballantyne, Synthetic Biologics' Chief Financial Officer, will review the Company's financial results for the three and six months ended June 30, 2014.

Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=100224. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=100224, for 30 days after the call.

Clinical Programs UpdateRelapsing-Remitting Multiple Sclerosis (RRMS) – Trimesta™ (oral estriol)Trimesta's differentiated dual mechanism of action, combined with the convenience of once-daily oral dosing, potentially make it an ideal therapy to address this underserved $14.1 billion worldwide market[i]. Based on previous research findings,[ii] Trimesta may offer both anti-inflammatory and neuro-protective benefits for patients with MS. Available MS therapies demonstrate anti-inflammatory or immunomodulatory effects, but in general are not considered neuro-protective agents.

MS Operational Highlights and Upcoming Milestones:

  • At the Americ
    '/>"/>

  • SOURCE Synthetic Biologics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (Pertussis) at 54th ICAAC
    2. Synthetic Biologics to Report Second Quarter 2014 Financial Results
    3. Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile
    4. Global Synthetic Biology Market 2014-2018
    5. Synthetic Biologics to Present at the 7th Annual OneMedForum San Francisco 2014 Conference
    6. Green Dot Develops Compostable Synthetic Leather Made with its Terratek® Flex Bioplastic
    7. Synthetic Biologics Announces Exercise of Underwriters Over-Allotment Option
    8. Synthetic Biologics Announces Proposed Public Offering of Common Stock
    9. Global Geosynthetics Market 2012-2016
    10. Process holds promise for production of synthetic gasoline
    11. Startup to Strengthen Synthetic Biology and Regenerative Medicine Industries with Cutting Edge Cell Products
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Markets and Companies" to their offering. ... markets based on technologies and applications. The report ... basis for estimation of markets. Technologies include array ...
    (Date:9/2/2015)... 02, 2015 ... announced the addition of Jain PharmaBiotech,s new ... Companies" to their offering. ... besides fluorescence in situ hybridization (FISH), comparative ... cytogenetics includes application of nanobiotechnology, microarrays, real-time ...
    (Date:9/2/2015)... , Sept. 2, 2015 Australian prostate ... a prestigious Australian science prize recognising ,outstanding, science that ... track to globally launch a novel prostate cancer diagnostic ... a high level consortium taking out the peer-reviewed Australian ... Scientific Research. This prize is awarded ...
    (Date:9/2/2015)... ZIONA, Israel , September 2, ... TASE: BVXV) today announced the intent of the National Institute ... National Institutes of Health (NIH) within the Department of Health ... trial to be held in the United States ... the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), ...
    Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
    ... Oct. 29 MannKind,Corporation (Nasdaq: MNKD ) will ... 5, 2008 at 8:00 a.m. EST., Management of ... the,third quarter financial results, clinical progress and other Company,developments ... from the,Company will be its Chairman and Chief Executive ...
    ... (Nasdaq: SGMO ) today reported third quarter 2008,financial ... September 30, 2008, Sangamo reported a,consolidated net loss of ... loss of $4.3 million, or $0.11 per share, for ... the company had cash, cash equivalents and,investments of $59.5 ...
    ... Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced that executives ... at two upcoming industry and/or investor,conferences:, -- Nov. ... the,New York Palace Hotel, 455 Madison Ave. in New ... president, is scheduled to present,at 9:55 a.m. EST., ...
    Cached Biology Technology:MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Trubion Announces Presentations at Upcoming Investor Conferences 2
    (Date:8/6/2015)... 2015  Today, U.S. Congressman Mike Honda ... to learn firsthand how Silicon Valley technologies can ... a world leader in multi-factor identity management and ... federal agencies and commercial organizations achieve new levels ... "The vast majority of network breaches can be ...
    (Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
    (Date:8/4/2015)... 2015 Research ... the addition of the "Digital Forensics ... Sub-Segment (Computer Forensics, Network Forensics, Mobile Device ... Vertical and Region - Global Forecast to ... By Component (Hardware, Software, and Service), ...
    Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
    ... gene they suspect plays an important role in triggering ... century-and-a-half ago. , And the pathogen that contains this ... the modern world?on the order of billions of dollars ... Avr3a, in a study that appears online in the ...
    ... Created as an alternate route of drug administration to ... skin patches are rapidly becoming an important healthcare product ... of chronic conditions such as angina, hypertension and HRT, ... transdermal patches for a host of new conditions wind ...
    ... Microarray technology can be used to identify each stage ... newly published report. , Melanomas grow in two phases: ... metastasize (spread cancer to other parts of the body) ... a large primary melanoma into radial and vertical portions, ...
    Cached Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3
    ... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
    biotin-4-fluorescein...
    Human IL-17D Affinity Purified Polyclonal Ab...
    Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
    Biology Products: